Cyteir Therapeutics, Inc. announced the roles of Chief Business Officer and Chief Scientific Officer have been eliminated as part of the workforce reduction. Andrew Gengos, the Company's Chief Business Officer will separate from the Company effective February 3, 2023 and Paul Secrist, Ph.D., the Company's Chief Scientific Officer will separate from the Company effective April 1, 2023.